Inventor · disambiguated record
Yue Li
Also filed as: LI YUE · LI YUE H · LI YUE HU
12 granted patents·9 pending applications·118 citations·filing 2002–2023
89Inventor score
Top patents by PatentIndex Score
21 records- 0194US8685980B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT EBAI·Filed 2009·Granted Apr 1, 2014·81 cites·15 claims
- 0291US11970480B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Granted Apr 30, 2024·2 cites·16 claims
- 0384US9416136B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2014·Granted Aug 16, 2016·8 cites·23 claims
- 0483US8410264B2Heterocyclic oxime compoundsDAI MIAO·Filed 2010·Granted Apr 2, 2013·9 cites·17 claims
- 0583US8206718B2Expression and export of angiogenesis inhibitors as immunofusinsLO KIN-MING·Filed 2006·Granted Jun 26, 2012·5 cites·4 claims
- 0682US11976057B2MrgX2 antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted May 7, 2024·1 cites·20 claims
- 0782US2024043428A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0879US8703908B2Expression and export of angiogenesis inhibitors as immunofusinsLO KIN-MING·Filed 2012·Granted Apr 22, 2014·3 cites·17 claims
- 0976US8497368B2Heterocyclic hydrazone compoundsHE FENG·Filed 2010·Granted Jul 30, 2013·4 cites·18 claims
- 1073US2021253578A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1171US8507676B2Heterocyclic oxime compoundsDAI MIAO·Filed 2012·Granted Aug 13, 2013·2 cites·15 claims
- 1266US7375131B2NF-κB inhibitorsSMITHKLINEBEECHAM CORP·Filed 2003·Granted May 20, 2008·3 cites·9 claims
- 1364US2018155351A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1456US2025179087A1Compounds and their uses as lpar5 antagonistsIMMUNOPHAGE BIOTECH SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1556US2017183352A1Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2016·Application pending·0 cites
- 1652US2003139365A1Expression and export of angiogenesis inhibitors as immunofusinsFiled 2002·Application pending·0 cites
- 1744US7183311B2NF-κB inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Feb 27, 2007·0 cites·23 claims
- 1844US2009069302A1Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2007·Application pending·0 cites
- 1939US2006116419A1Nf-kb inhibitorsCALLAHAN JAMES F·Filed 2003·Application pending·0 cites
- 2036US2007249670A1Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions ThereofSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 2135US10975287B2Heterocyclic amides useful as protein modulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 13, 2021·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →